Article · Volume 12, Issue 3 · pp. 280-284

Physicians’ Knowledge and Awareness about Biosimilars in Saudi Arabia: What is Imperative to Know ??

Ziyad Saeed Almalki¹, Muhammad Shahid Iqbal¹, Manal Abdullah Alossaimi², Alwaleed Mohammed Lasaf¹, Bandar Abdullah Almawash¹, Fayez Hamoud Aldossary¹, Aliyah Mohammed Marghalani³, Yazeed Abdulaziz Alsubaihi¹

¹Department of Clinical Pharmacy, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-kharj, SAUDI ARABIA.
²Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam bin Abdulaziz University, Al-Kharj, SAUDI ARABIA.
³College of Pharmacy, Taif University, Taif, SAUDI ARABIA.

Abstract

Objectives: This study determined the current awareness and knowledge among physicians about biosimilars in Saudi Arabia.Methods: This study used a cross-sectional study design and data were acquired by the convenience sampling method. The research tool was self-developed, prevalidated and self-administered to achieve the sample size. The physicians from various parts of the country participated in the study. Both, inferential statistics with the help of descriptive statistics were applied using the Statistical Package for Social Sciences (SPSS) version 24.0 and Microsoft Excel. A p-value 0.05) was observed.Conclusion: It is concluded that the study physicians had adequate knowledge and awareness about biosimilars in Saudi Arabia. Statistically, a non-significant association (p <0.05) was observed between adequate and inadequate knowledge among the studied physicians in Saudi Arabia.

Keywords: Biosimilars; Physicians; Knowledge; Awareness; Saudi Arabia

The full text of this article, with its figures and tables, is its PDF, shown below. Open the PDF in a new tab.